Lipid based liquid-crystalline stabilized formulations for the sustained release of bioactive hydrophilic molecules

Anti-corrosive non-aqueous DBSA/MEA lamellar liquid crystal lubrication system

HYPOTHESIS

Since lamellar liquid crystals (LLCS) could be used for lubrication, many LLCS systems have been constructed to improve lubrication performance. However, most studies focused on the LLCS of the water system, and its corrosiveness brought some limitations to its application. Therefore, it is necessary to construct a non-aqueous LLCS system with good lubrication and anti-corrosion properties to improve its applicability.

EXPERIMENTS

Anionic surfactant dodecyl benzene sulfonic acid (DBSA) was used to construct non-aqueous LLCS in different solvents, including monoethanolamine (MEA) and diethanolamine (DEA). DBSA/H₂O LLCS system was constructed for comparison. The LLCS was characterized by polarizing microscope (POM), small-angle X-ray scattering (SAXS), and rheology. Its microstructure was discussed. Meanwhile, we evaluated the lubrication and anti-corrosion performance of LLCS. Its lubrication mechanism was explained through tribology tests and X-ray photoelectron spectrometer (XPS) analysis of the wear scar surface. Its anti-corrosion mechanism was investigated by using the weightlessness method, electrochemical test method, and quantum chemical theoretical calculations.

FINDINGS

The DBSA/MEA non-aqueous LLCS system showed better lubrication performance than DBSA/DEA and DBSA/H₂O LLCS. It can adsorb on the surface of the friction pair to form a lubrication friction film, which plays a better role in reducing friction and wear. The DBSA/MEA LLCS is less corrosive to metals because it can effectively isolate oxygen and water in the air between friction pairs. Furthermore, the lone pair electrons in the 2p orbital of the N atom in the MEA molecule could coordinate with the 3d empty orbital of the Fe atom, forming a protective film on the metal surface, which plays a good anti-corrosion effect. This work not only enriched the study of non-aqueous LLCS but also expanded its potential applications in the field of lubrication.

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits

In the current research, novel drug delivery systems based on in situ forming gel (ISFG) (PLGA-PEG-PLGA) and in situ forming implant (ISFI) (PLGA) were developed for one-month risperidone delivery. In vitro release evaluation, pharmacokinetics, and histopathology studies of ISFI, ISFG, and Risperdal CONSTA^® were compared in rabbits. Formulation containing 50% (w/w %) of PLGA-PEG-PLGA triblock revealed sustained release for about one month. Scanning electron microscopy (SEM) showed a porous structure for ISFI, while a structure with fewer pores was observed in the triblock. Cell viability in ISFG formulation in the first days was more than ISFI due to the gradual release of NMP to the release medium. Pharmacokinetic data displayed that optimal PLGA-PEG-PLGA creates a consistent serum level in vitro and in vivo through 30 days, and histopathology results revealed nearly slight to moderate pathological signs in the rabbit's organs. The shelf life of the accelerated stability test didn't affect the results of the release rate test and demonstrated stability in 24 months. This research confirms the better potential of the ISFG system compared with ISFI and Risperdal CONSTA^®, which would increase patients' compliance and avoid problems of further oral therapy.

Lipidic lyotropic liquid crystals: Insights on biomedical applications

Liquid crystals (LCs) possess unique physicochemical properties, translatable into a wide range of applications. To date, lipidic lyotropic LCs (LLCs) have been extensively explored in drug delivery and imaging owing to the capability to encapsulate and release payloads with different characteristics. The current landscape of lipidic LLCs in biomedical applications is provided in this review. Initially, the main properties, types, methods of fabrication and applications of LCs are showcased. Then, a comprehensive discussion of the main biomedical applications of lipidic LLCs accordingly to the application (drug and biomacromolecule delivery, tissue engineering and molecular imaging) and route of administration is examined. Further discussion of the main limitations and perspectives of lipidic LLCs in biomedical applications are also provided. STATEMENT OF SIGNIFICANCE: Liquid crystals (LCs) are those systems between a solid and liquid state that possess unique morphological and physicochemical properties, translatable into a wide range of biomedical applications. A short description of the properties of LCs, their types and manufacturing procedures is given to serve as a background to the topic. Then, the latest and most innovative research in the field of biomedicine is examined, specifically the areas of drug and biomacromolecule delivery, tissue engineering and molecular imaging. Finally, prospects of LCs in biomedicine are discussed to show future trends and perspectives that might be utilized. This article is an ampliation, improvement and actualization of our previous short forum article "Bringing lipidic lyotropic liquid crystal technology into biomedicine" published in TIPS.

In situ preparation of hydroxyapatite in lamellar liquid crystals for joint lubrication and drug delivery

Arthritis is a disease that seriously affects the quality of human life, which is partly caused by the reduction of joint lubrication performance. Thus, for the treatment of arthritis, how to improve the lubrication performance of joints is important. The lamellar liquid crystals (LLCs) systems have the potential to be used as joint lubrication due to their double-layer structure and good biocompatibility, however, the LLCs system alone could not provide a satisfactory lubrication effect. Herein, this work synthesized hydroxyapatite (HAP) in situ inside Tween 85/Tween 80/H₂O LLCs to construct a biocompatible HAP/Tween 85/Tween 80/H₂O LLCs (HAP/LLCs) lubrication system with both sustained drug release properties and anti-wear properties. HAP is the main component of bone with good stability and bioactivity. The LLCs have good lubricating and drug-carrying properties. The impact of HAP on the structure and lubrication properties of LLCs, the mechanism of friction, and the anti-wear reduction of HAP/LLCs were investigated. Moreover, the drug release behavior of the ibuprofen-loaded HAP/LLCs during the friction process was also studied. The results indicated that the addition of HAP could improve the lubricity performance of LLCs. The cumulative drug releasing increased with the friction frequency and was less affected by the load. The related studies provided the theoretical basis for HAP/LLCs for joint lubrication and synergistic therapy.

Smart phase transformation system based on lyotropic liquid crystalline@hard capsules for sustained release of hydrophilic and hydrophobic drugs

Smart phase transformation systems@hard capsule (SPTS@hard capsule) based on lyotropic liquid crystalline (LLC) were developed for oral sustained release in this study. Doxycycline hydrochloride (DOXY) and meloxicam (MLX) were used as hydrophilic and hydrophobic model drug, respectively. Two systems were added with different additives, that is, gelucire 39/01, PEG 1000 and Tween 80 to adjust their melting point and release profiles. The phase transformation of these systems could be triggered by water as well as temperature. They could spontaneously transform into cubic phase or hexagonal phase when coming across with water, to achieve the 24 h sustained release profile. In addition, the obtained systems could switch between semisolid state and liquid state when temperature changed within room temperature and body temperature, which facilitated the phase transformation in gastrointestinal tract and during their encapsulation into hard capsules. LLC-based SPTS@hard capsule revealed potential for the industrialization of its oral administration on account of its drugs accommodation with different solubility, controllable release profile and simple preparation process.

The Evaluations of Menthol and Propylene Glycol on the Transdermal Delivery System of Dual Drug-Loaded Lyotropic Liquid Crystalline Gels

This study aimed to evaluate the effects of two different structural alcohol permeation enhancers (menthol and propylene glycol) on the internal structure and in vitro properties of the dual drug-loaded lyotropic liquid crystalline (LLC) gels. The LLC gels were prepared and characterized by polarized light microscopy, small-angle X-ray scattering, differential scanning calorimetry, attenuated total reflectance-Fourier transform infrared spectrum, and rheology. Based on the results, the inner structure of the gels was Q_II mesophase and exhibited a pseudoplastic fluid behavior. The level of internal order in the LLC mesophase would be affected by introduced 2 wt% menthol (MEN) and propylene glycol (PG). The in vitro release experiment showed that the release behavior of sinomenine hydrochloride (SH) and cinnamaldehyde (CA) from the LLC system was dominated by Fickian diffusion (n < 0.43). MEN and PG had the opposite effects on the release of hydrophilic SH, while the MEN and PG both increased the release of lipophilic drug CA. Furthermore, in vitro permeation studies indicated that MEN and PG could both improve the skin permeability of SH and CA, and MEN displayed more pronounced enhancement. All the samples showed no skin irritation on the normal rat skin. Collectively, in our research, monoterpenoid MEN exhibited a better penetration-promoting effect than straight-chain fatty alcohol PG on the dual drug-loaded LLC system.

Molecular Behavior of Linear Alkylbenzene Sulfonate in Hydrated Crystal, Tilted Gel, and Liquid Crystal Phases Studied by Molecular Dynamics Simulation

The lamellar phase produced by surfactants with water exhibits several subphases, such as hydrated crystal (L_c), gel (L_β), tilted gel (L_β'), and liquid crystal (L_α) phases, depending on temperature, pressure, and hydration. The dynamics of the surfactant molecules in these phases are still unclear. In the present study, we investigate the translational and conformational dynamics of sodium linear alkylbenzene sulfonate (LAS) molecules in the L_c, L_β', and L_α phases. In the L_α phase, the lateral diffusion of LAS is as fast as that found for phospholipid bilayers in the L_α phase. The diffusion coefficient was undetectably small for the L_c and L_β' phases. The conformation of LAS in the L_α phase relaxes very rapidly, whereas those in the L_c and L_β' phases relax very slowly. The time scale of the relaxations greatly depends on the segment of the LAS molecule for the latter two phases. The relaxation time for the SO₃^- head group and benzene ring of LAS was much longer than that for alkyl chains. Conformational pattern analyses of LAS alkyl chains revealed that the high fraction of the gauche conformation for the odd-numbered C-C bonds aligns the chain parallel to the bilayer normal and is the main origin of the different relaxation times for different segments in the chain. In the L_c, L_β', and L_α phases, the orientations of the SO₃^- group and the benzene ring are locked by the salt bridge among SO₃^- groups and sodium ions. As a result, the orientational order found for the C-C bonds in the LAS alkyl chains is kept even in the L_α phase.